Xerimis Announces the Debut of Its Purpose-Built, 13,000-Square-Foot United Kingdom Facility
Xerimis announces the debut of its purpose-built, 13,000-square foot United Kingdom facility – the second location for the privately held, New Jersey-headquartered customized clinical packaging provider.
EventNovember 30 – December 1, 2016
Continue Reading
Seoul, Korea
Xerimis to exhibit at Clinical Trial Supply-East Asia / Exhibit
This event runs from November 30 – December 1, 2016, in Seoul, Korea. Visit Xerimis at Booth #19.
EventNovember 13-17, 2016
AAPS (American Association of Pharmaceutical Scientists / Exhibit
Continue Reading Denver, CO
EventNovember 3, 2016
Xerimis to attend the NECSO Meeting (New England Clinical Supplies Organization)
Continue Reading Cambridge, MA
EventOctober 19-20, 2016
Xerimis to exhibit at Clinical Trial Supply-East Coast / Exhibit
Continue Reading Princeton, NJ
EventOctober 11, 2016
Xerimis to exhibit at Triangle Biotech Research Symposium V / Exhibit
Continue Reading Durham, NC
EventOctober 18-20, 2016
Xerimis to exhibit at the Global Clinical Supplies Group (GCSG) – European Conference / Exhibit
Continue Reading St. Julian’s, MaltaXerimis Expands Controlled Substances Capabilities
Xerimis Inc. has been approved by the DEA as a registered distributor of schedule 3 through 5 controlled substances.
Carol Sue Bernardo Named Chief Executive Officer of Xerimis Inc.
Xerimis Inc. is proud to announce that Carol Sue Bernardo, Executive Vice President, has been named Chief Executive Officer.